ZHONG JI LS(00767) intends to cooperate with China Aviation Health to jointly carry out businesses such as longevity testing and longevity management.

Company ZHONG JI LS (00767) announced that on August 8, 2025, its wholly-owned subsidiary Hong Feng Development Co., Ltd. (Hong Feng Development) signed a cooperation memorandum with Shenzhen Zhonghang Health Fashion Group Co., Ltd. (Zhonghang Health). According to this agreement, Hong Feng Development and Zhonghang Health will collaborate on longevity testing, longevity management, and other related businesses, providing customers with longevity bioproducts, longevity medical testing, health consultation services, longevity management, and other products and services in the health industry. Zhonghang Health is a limited company founded in China in 1998. It is a national high-tech enterprise that integrates sports health, health management, and comprehensive medical care, providing customers with professional, personalized, and comprehensive health solutions. The group currently has over 600,000 registered customers, providing specialized and systematic employee health management services to over 300 world-class enterprises, serving millions of people annually. The group adheres to a business model centered on "innovation in technology and services", actively exploring and innovating in the field of health care based on its industry-leading technological advantages, making it a leader in China's health management service industry. The Board of Directors believes that the prospects for the health and longevity science market are promising, as affluent customers around the world are increasingly willing to invest in longevity science applications to enhance their overall health and immunity and promote a more youthful body. Furthermore, the signing of the memorandum and the cooperation align with the group's strategic development plans for the longevity science business, which will benefit the group's future business expansion. The Board of Directors believes that the potential cooperation will further enhance the group's presence in the field of longevity science diagnostics and medical services, opening up new sources of revenue in longevity science for the company and bringing a more stable and sustainable income growth in the long term.